Praxis Precision Medicines, Inc. - Common Stock, par value $0.0001 per share (PRAX)

Q: What does CUSIP 74006W207 represent in this 13F holders report?

CUSIP 74006W207 is the security identifier for PRAX - Praxis Precision Medicines, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held PRAX - Praxis Precision Medicines, Inc. - Common Stock, par value $0.0001 per share in Q4 2023?

57 institutional investors reported PRAX - Praxis Precision Medicines, Inc. - Common Stock, par value $0.0001 per share for Q4 2023. Use the holders table for investor-level position and value details.

CUSIP: 74006W207

Q4 2023 13F Holders as of 31 Dec 2023

Security type / class: Equity / Common Stock, par value $0.0001 per share
Total 13F shares: 7,555,380
Total 13F value: $168,332,336
Share change: +7,555,380
Put/Call ratio: 2.8%
SEC-reported price per share: $22.28
Number of holders: 57
Value change: +$168,332,336
Number of buys: 57
Shares outstanding: 27,828,540

Security key

74006W207

Report period

Q4 2023

Institutions

Top holders

PRAX full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2026 Praxis Precision Medicines, Inc. SEC filings Praxis Precision Medicines, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 74006W207

Newer quarter: Q2 2026

Recent filing periods:

Q2 2026

Ownership snapshot

Top reported holders of PRAX - Praxis Precision Medicines, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Clarus Lifesciences III, ...

Disclosed value leader

Clarus Lifesciences III, ...

Comparable rows

0/15

Latest evidence

30 Sep 2023

3/4/5 13F Highest disclosed value: $123,282,606 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Clarus Lifesciences III, L.P. has the largest disclosed position value at $123.28M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Clarus Lifesciences III, L.P.'s linked filing trail.

Disclosed position value Top 5

Clarus Lifesciences III, L.P. $123.28M

Point72 Asset Management, L.P. $17.76M

Cormorant Asset Management, LP $16.24M

Verition Fund Management LLC $15.49M

PFM Health Sciences, LP $15.25M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Clarus Lifesciences III, L.P.	3/4/5 10%+ Owner 3/4/5	— class O/S missing	$123,282,606 4,894,109 shares	—	12 May 2021
Point72 Asset Management, L.P.	13F Company 13F	— class O/S missing	$17,756,264 10,383,780 shares	—	30 Sep 2023
Cormorant Asset Management, LP	13F Company 13F	— class O/S missing	$16,245,000 9,500,000 shares	—	30 Sep 2023
Verition Fund Management LLC	13F Company 13F	— class O/S missing	$15,492,325 9,059,839 shares	—	30 Sep 2023
PFM Health Sciences, LP	13F Company 13F	— class O/S missing	$15,253,195 8,919,997 shares	—	30 Sep 2023
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F Company 13F	— class O/S missing	$15,013,800 8,780,000 shares	—	30 Sep 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

7,555,380

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders

Q4 2023 holders

Holder diff

Investor	Q3 2023 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2023 value	Q4 2023 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend